Lifeline Biotech (LLBO) 0.0010 $LLBO Lifeline B
Post# of 273249
Posted On: 06/19/2016 6:02:38 PM
Lifeline Biotech (LLBO) 0.0010 $LLBO
Lifeline Biotechnologies Updates Current Matters
Marketwire Canada - Mon Jun 13, 4:47PM CDT
RENO, NV--(Marketwired - Jun 13, 2016) - Lifeline Biotechnologies, Inc. ("The Company"
(OTC PINK: LLBO) updates its shareholders and provides information to the public.
Lifeline Biotechnologies Announces a Cyrcadia Milestone and 2016 Expectations
Marketwired - Fri Apr 01, 7:00AM CDT
Lifeline Biotechnologies, Inc. ("The Company" (OTC PINK: LLBO), in conjunction with its affiliate Cyrcadia, Inc. (" Cyrcadia", is pleased to announce the achievement of a major milestone in Cyrcadia's regulatory and business development path. Cyrcadia Health announced the extension of its clinical trial for early breast cancer detection to The Stefanie Spielman Comprehensive Breast Center at The Ohio State University, in Columbus, Ohio. The trial, which began in 2015 at El Camino Hospital, in Mountain View, California, will continue at both locations to reach enrollment of 173 patients focused on breast cancer health screening.
Lifeline's Affiliate, Cyrcadia Commences Clinical Trial
Marketwired - Tue Jul 07, 8:58AM CDT
Lifeline (OTC PINK: LLBO) and Cyrcadia, Inc. ("Cyrcadia" announce that Cyrcadia has commenced a clinical trial for its wearable early detection of breast cancer device and is enrolling the first trial participants at El Camino Hospital, in Mountain View, California. Utilizing its previous FDA cleared device as a predicate, Cyrcadia is combining its fourth generation, wearable device technology, made by Flextronics, and the Salesforce database software to track the clinical trial results.
Lifeline Biotechnologies (LLBO) Q1 2015 Update
Marketwired - Thu Mar 12, 12:17PM CDT
The Company (OTC PINK: LLBO) (PINKSHEETS: LLBO) updates the meaningful activities for First Quarter of 2015:
Depository Trust Company Chill Removed
ACCESSWIRE - Fri Dec 19, 12:58PM CST
RENO, NV / ACCESSWIRE / December 19, 2014 / The Company (OTC Pink: LLBO) (PINKSHEETS: LLBO) is pleased to announce that Depository Trust Company's (DTCC) chill has been removed and the Company's common stock is once again tradable on both the buy and sell side on OTC Pink.
Company Files OTC Market Disclosures Documents, Stop Sign Removed
ACCESSWIRE - Wed Nov 19, 7:46AM CST
RENO, NV / ACCESSWIRE / November 19, 2014 / The Company (OTC Pink: LLBO) (PINKSHEETS: LLBO) has filed with OTC Markets (www.OTCMarkets.com) all of the required disclosure statements in order to be considered as providing current information to the public. As a result OTC Markets has removed the "Stop Sign" and re-established Lifeline Biotechnologies as OTC Pink - Current Information.
Lifeline Biotechnologies Updates Current Matters
Marketwire Canada - Mon Jun 13, 4:47PM CDT
RENO, NV--(Marketwired - Jun 13, 2016) - Lifeline Biotechnologies, Inc. ("The Company"
(OTC PINK: LLBO) updates its shareholders and provides information to the public. Lifeline Biotechnologies Announces a Cyrcadia Milestone and 2016 Expectations
Marketwired - Fri Apr 01, 7:00AM CDT
Lifeline Biotechnologies, Inc. ("The Company"
(OTC PINK: LLBO), in conjunction with its affiliate Cyrcadia, Inc. (" Cyrcadia", is pleased to announce the achievement of a major milestone in Cyrcadia's regulatory and business development path. Cyrcadia Health announced the extension of its clinical trial for early breast cancer detection to The Stefanie Spielman Comprehensive Breast Center at The Ohio State University, in Columbus, Ohio. The trial, which began in 2015 at El Camino Hospital, in Mountain View, California, will continue at both locations to reach enrollment of 173 patients focused on breast cancer health screening. Lifeline's Affiliate, Cyrcadia Commences Clinical Trial
Marketwired - Tue Jul 07, 8:58AM CDT
Lifeline (OTC PINK: LLBO) and Cyrcadia, Inc. ("Cyrcadia"
announce that Cyrcadia has commenced a clinical trial for its wearable early detection of breast cancer device and is enrolling the first trial participants at El Camino Hospital, in Mountain View, California. Utilizing its previous FDA cleared device as a predicate, Cyrcadia is combining its fourth generation, wearable device technology, made by Flextronics, and the Salesforce database software to track the clinical trial results. Lifeline Biotechnologies (LLBO) Q1 2015 Update
Marketwired - Thu Mar 12, 12:17PM CDT
The Company (OTC PINK: LLBO) (PINKSHEETS: LLBO) updates the meaningful activities for First Quarter of 2015:
Depository Trust Company Chill Removed
ACCESSWIRE - Fri Dec 19, 12:58PM CST
RENO, NV / ACCESSWIRE / December 19, 2014 / The Company (OTC Pink: LLBO) (PINKSHEETS: LLBO) is pleased to announce that Depository Trust Company's (DTCC) chill has been removed and the Company's common stock is once again tradable on both the buy and sell side on OTC Pink.
Company Files OTC Market Disclosures Documents, Stop Sign Removed
ACCESSWIRE - Wed Nov 19, 7:46AM CST
RENO, NV / ACCESSWIRE / November 19, 2014 / The Company (OTC Pink: LLBO) (PINKSHEETS: LLBO) has filed with OTC Markets (www.OTCMarkets.com) all of the required disclosure statements in order to be considered as providing current information to the public. As a result OTC Markets has removed the "Stop Sign" and re-established Lifeline Biotechnologies as OTC Pink - Current Information.
(0)
(0)Scroll down for more posts ▼